Prostacycline. No CYP-interactions.

(To be edited, initial data ST OCT 04) Prostacycline analogue inhibiting platelet reactions .Used in severe chronic peripheral circulatory insufficiency with impending risk for amputation Administered as infusion 0.5-2.0 ng/kg BW/ min. Metabolized by beta-oxidation.